Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium tungstate for weight loss in grade I-II obesity
NCT00555074Phase 2Completed
- Sponsor
- Hospital Clínic de Barcelona
- Start
- Nov 2007
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in obesity comparing Sodium Tungstate with Placebo (2 arms). Primary endpoint: Weight loss at 6 weeks. Started Nov 2007; status: completed.
02
Drugs
sodium tungstate
03
Conditions
obesity
Beyond the preview
Go deeper on NCT00555074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00555074.